Bill is chair of the firm’s biotechnology and life sciences team, and previously led Eversheds Sutherland (US)’s Intellectual Property Practice Group. He also protects trademarks and copyrights and, when necessary, participates in litigating intellectual property issues. In particular, he counsels various entities on Hatch-Waxman generic pharmaceutical and related biosimilars issues. For more than two decades, Bill has worked with clients ranging from multinational corporations, to early-stage entrepreneurial companies, to nonprofit university and science research centers. He is a frequent speaker and writer on developments in patent law affecting the life sciences industry.
Conducted freedom-to-operate analyses for the commercialization of therapeutic recombinant proteins and monoclonal antibodies for a global specialty pharmaceutical company.
Completes diligence on the acquisition and licensing of bead-based molecular bioarray nucleic acid detection platform technology.
Advises a medical device company on patenting cardiovascular access and closure products.
Awards and Rankings
Selected for inclusion in IP Starsby Managing Intellectual Property (2013-2017)
Named among “Georgia’s Legal Elite” by Georgia Trend magazine (2007)
Selected for inclusion in Georgia Super Lawyers “Rising Stars” (2005-2006)
Vice-Chair, Intellectual Property Owners Committee, Genetic Resources and Traditional Knowledge
Member, American Bar Association
Member, Atlanta Bar Association
Member, State Bar of Georgia, Intellectual Property Law Section
General Counsel and Board Member, Georgia Biotechnology Industry Organization
Member, American Intellectual Property Law Association
Member, Intellectual Property Owners Association
Member, Bioscience Leadership Council, Metro Atlanta Chamber of Commerce
Member, Licensing Executives Society
Member, Association for University Technology Managers
Member, Board of Councilors, The Carter Center
Trustee, Chi Psi Fraternity Educational Trust
Trustee, Fernbank Museum of Natural History